GDS.PA • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold GDS.PA in your mock portfolio yet.
The negative EPS and correspondingly negative PE ratio indicate that Ramsay Générale de Santé SA is currently loss‑making. This suggests pressure on margins and/or elevated costs, with no clear evidence from the provided data that a return to sustained profitability is imminent. In the absence of positive earnings, the equity story is more about turnaround potential than current financial strength.
The stock trades at €9.00, modestly up 0.4% over the last month, but still below its 200‑day moving average of €9.97, indicating a weak intermediate trend. An RSI of 43.97 is neutral‑to‑slightly weak, suggesting neither oversold nor overbought conditions but a lack of strong buying momentum. Overall, technicals lean mildly bearish, with price action reflecting subdued investor conviction.
Alternative data for Ramsay Générale de Santé SA present a mixed picture. Digital reach via social media is generally stable to improving, while app downloads are flat and web traffic appears modest. The notable decline in job openings may signal either efficiency measures or a cautious stance on growth, making the overall alternative‑data signal broadly neutral.
Considering the negative earnings profile, subdued price action below the 200‑day moving average, and only neutral alternative‑data signals, the overall stance on Ramsay Générale de Santé SA is bearish at this time. The equity case hinges on a future earnings recovery that is not yet evident in the provided metrics.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: